2. We select a group of 1,000 middle-aged volunteers without kidney disease who are likely to suffer from insomnia/anxiety. We assign them randomly into two groups. Group 1 is told to live their lives as normal and take any meds proscribed by their doctor. Group 2 is told not to use BZDS for 2 years, and doctors prescribe Group 2 with natural alternatives to BZDS. After those 2 years, we follow them up and check to see who developed kidney disease in each group, and compare the groups. 3. We will get the age-adjusted incidence rates of kidney disease in 30 different countries Jand compare those with the rates of BZD consumption per capita (total usage in country/ total population of that country). We will then check to see if there is a correlation between the BZD consumption and kidney disease. 4. In 2010, we examined the medical records of 2,000 patients ages 53+ associated with Kaiser Permanente (large health care organization) who did NOT have kidney disease in 2005. Then, we look back in the records to see who took BZDS from 2000-2005. After that, we look to see who developed kidney disease from 2006 until 2008. We compared the rates of kidney disease among those who took the BZDS and those who didn't.

MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
icon
Related questions
Question
12. We select a group of 1,000 middle-aged volunteers without kidney disease who are likely
to suffer from insomnia/anxiety. We assign them randomly into two groups. Group 1 is
told to live their lives as normal and take any meds proscribed by their doctor. Group 2 is
told not to use BZDS for 2 years, and doctors prescribe Group 2 with natural alternatives
to BZDS. After those 2 years, we follow them up and check to see who developed kidney
disease in each group, and compare the groups.
13. We will get the age-adjusted incidence rates of kidney disease in 30 different countries
Jand compare those with the rates of BZD consumption per capita (total usage in country/
total population of that country). We will then check to see if there is a correlation
between the BZD consumption and kidney disease.
14. In 2010, we examined the medical records of 2,000 patients ages 53+ associated with
Kaiser Permanente (large health care organization) who did NOT have kidney disease in
2005. Then, we look back in the records to see who took BZDS from 2000-2005. After
that, we look to see who developed kidney disease from 2006 until 2008. We compared
the rates of kidney disease among those who took the BZDS and those who didn’t.
Transcribed Image Text:12. We select a group of 1,000 middle-aged volunteers without kidney disease who are likely to suffer from insomnia/anxiety. We assign them randomly into two groups. Group 1 is told to live their lives as normal and take any meds proscribed by their doctor. Group 2 is told not to use BZDS for 2 years, and doctors prescribe Group 2 with natural alternatives to BZDS. After those 2 years, we follow them up and check to see who developed kidney disease in each group, and compare the groups. 13. We will get the age-adjusted incidence rates of kidney disease in 30 different countries Jand compare those with the rates of BZD consumption per capita (total usage in country/ total population of that country). We will then check to see if there is a correlation between the BZD consumption and kidney disease. 14. In 2010, we examined the medical records of 2,000 patients ages 53+ associated with Kaiser Permanente (large health care organization) who did NOT have kidney disease in 2005. Then, we look back in the records to see who took BZDS from 2000-2005. After that, we look to see who developed kidney disease from 2006 until 2008. We compared the rates of kidney disease among those who took the BZDS and those who didn’t.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Similar questions
Recommended textbooks for you
MATLAB: An Introduction with Applications
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman